|
1
|
Deb P, Sharma S and Hassan KM:
Pathophysiologic mechanisms of acute ischemic stroke: An overview
with emphasis on therapeutic significance beyond thrombolysis.
Pathophysiology. 17:197–218. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fattahi S, Pilehchian Langroudi M and
Akhavan-Niaki H: Hedgehog signaling pathway: Epigenetic regulation
and role in disease and cancer development. J Cell Physiol.
233:5726–5735. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsubara N: Epigenetic regulation and
colorectal cancer. Dis Colon Rectum. 55:96–104. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krupinski J, Carrera C, Muino E, Torres N,
Al-Baradie R, Cullell N and Fernandez-Cadenas I: DNA methylation in
stroke. update of latest advances. Comput Struct Biotechnol J.
16:1–5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsue SS, Wang WC, Chen YK and Lin LM:
Expression of inhibitors of apoptosis family protein in
7,12-dimethylbenz[a]anthracene-induced hamster buccal-pouch
squamous-cell carcinogenesis is associated with mutant p53
accumulation and epigenetic changes. Int J Exp Pathol. 89:309–320.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bykov VJN, Eriksson SE, Bianchi J and
Wiman KG: Targeting mutant p53 for efficient cancer therapy. Nat
Rev Cancer. 18:89–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mayr U, Mayr M, Li C, Wernig F, Dietrich
H, Hu Y and Xu Q: Loss of p53 accelerates neointimal lesions of
vein bypass grafts in mice. Circ Res. 90:197–204. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mendrysa SM, Ghassemifar S and Malek R:
p53 in the CNS: Perspectives on development, stem cells, and
cancer. Genes Cancer. 2:431–442. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X: Diagnostic essentials of various
cerebrovascular diseases. Chin J Neurol. 29:379–381. 1996.
|
|
10
|
Li LC and Dahiya R: MethPrimer: Designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang JH, Kim SJ, Noh DY, Park IA, Choe KJ,
Yoo OJ and Kang HS: Methylation in the p53 promoter is a
supplementary route to breast carcinogenesis: Correlation between
CpG methylation in the p53 promoter and the mutation of the p53
gene in the progression from ductal carcinoma in situ to invasive
ductal carcinoma. Lab Invest. 81:573–579. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou Y, Zheng X, Lu J, Chen W, Li X and
Zhao L: Ginsenoside 20(S)-Rg3 inhibits the warburg effect via
modulating DNMT3A/MiR-532-3p/HK2 pathway in ovarian cancer cells.
Cell Physiol Biochem. 45:2548–2559. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cohen SN, Chang AC and Hsu L:
Nonchromosomal antibiotic resistance in bacteria: Genetic
transformation of escherichia coli by R-factor DNA. Proc Natl Acad
Sci USA. 69:2110–2114. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bock C, Reither S, Mikeska T, Paulsen M,
Walter J and Lengauer T: BiQ analyzer: Visualization and quality
control for DNA methylation data from bisulfite sequencing.
Bioinformatics. 21:4067–4068. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim GH, Youn HJ, Choi YS, Jung HO, Chung
WS and Kim CM: Carotid artery evaluation and coronary calcium
score: Which is better for the diagnosis and prevention of
atherosclerotic cardiovascular disease? Int J Clin Exp Med.
8:18591–18600. 2015.PubMed/NCBI
|
|
16
|
Lee C and Huang CH: Searching for
transcription factor binding sites in vector spaces. BMC
Bioinformatics. 13:2152012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aslani S, Sobhani S, Gharibdoost F,
Jamshidi A and Mahmoudi M: Epigenetics and pathogenesis of systemic
sclerosis; the ins and outs. Hum Immunol. 79:178–187. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Masser DR, Hadad N, Porter H, Stout MB,
Unnikrishnan A, Stanford DR and Freeman WM: Analysis of DNA
modifications in aging research. Geroscience. 40:11–29. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lyu H, Huang J, He Z and Liu B: Epigenetic
mechanism of survivin dysregulation in human cancer. Sci China Life
Sci. 61:808–814. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
El Bairi K, Tariq K, Himri I, Jaafari A,
Smaili W, Kandhro AH, Gouri A and Ghazi B: Decoding colorectal
cancer epigenomics. Cancer Genet. 220:49–76. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
James E and Jenkins TG: Epigenetics,
infertility, and cancer: Future directions. Fertil Steril.
109:27–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mayer W, Niveleau A, Walter J, Fundele R
and Haaf T: Demethylation of the zygotic paternal genome. Nature.
403:501–502. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong LZ, Zhao XY and Zhang HL:
p53-mediated neuronal cell death in ischemic brain injury. Neurosci
Bull. 26:232–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Crow MT: Revisiting p53 and its effectors
in ischemic heart injury. Cardiovasc Res. 70:401–403. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Crumrine RC, Thomas AL and Morgan PF:
Attenuation of p53 expression protects against focal ischemic
damage in transgenic mice. J Cereb Blood Flow Metab. 14:887–891.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Chen G, Gao X, Shen C, Zhou P, Wu X,
Che X and Xie R: p53 participates in the protective effects of
ischemic post-conditioning against OGD-reperfusion injury in
primary cultured spinal cord neurons. Neurosci Lett. 638:129–134.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Chopp M, Zhang ZG, Zaloga C,
Niewenhuis L and Gautam S: p53-immunoreactive protein and p53 mRNA
expression after transient middle cerebral artery occlusion in
rats. Stroke. 25:849–856. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hai Z and Zuo W: Aberrant DNA methylation
in the pathogenesis of atherosclerosis. Clin Chim Acta. 456:69–74.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hiltunen MO, Turunen MP, Hakkinen TP,
Rutanen J, Hedman M, Mäkinen K, Turunen AM, Aalto-Setälä K and
Ylä-Herttuala S: DNA hypomethylation and methyltransferase
expression in atherosclerotic lesions. Vasc Med. 7:5–11. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Newman PE: Can reduced folic acid and
vitamin B12 levels cause deficient DNA methylation producing
mutations which initiate atherosclerosis? Med Hypotheses.
53:421–424. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Turunen MP, Aavik E and Yla-Herttuala S:
Epigenetics and atherosclerosis. Biochim Biophys Acta.
1790:886–891. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Durand P, Prost M, Loreau N, Lussier-Cacan
S and Blache D: Impaired homocysteine metabolism and
atherothrombotic disease. Lab Invest. 81:645–672. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mok V and Kim JS: Prevention and
management of cerebral small vessel disease. J Stroke. 17:111–122.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Joseph J and Loscalzo J: Methoxistasis:
Integrating the roles of homocysteine and folic acid in
cardiovascular pathobiology. Nutrients. 5:3235–3256. 2013.
View Article : Google Scholar : PubMed/NCBI
|
